Shopping Cart
- Remove All
- Your shopping cart is currently empty
LeuRS-IN-2 (Compound 9) acts as an inhibitor of Wolbachia Leucyl-tRNA synthetase (LeuRS) in the presence of adenosine monophosphate (AMP), exhibiting an EC50 value of 6 nM and effectively inhibiting the growth of pathogenic hosts. It forms an adenosine adduct to hinder protein synthesis and shows promise in studies aimed at developing new antimicrobial agents targeting microbial communities.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | LeuRS-IN-2 (Compound 9) acts as an inhibitor of Wolbachia Leucyl-tRNA synthetase (LeuRS) in the presence of adenosine monophosphate (AMP), exhibiting an EC50 value of 6 nM and effectively inhibiting the growth of pathogenic hosts. It forms an adenosine adduct to hinder protein synthesis and shows promise in studies aimed at developing new antimicrobial agents targeting microbial communities. |
In vitro | LeuRS-IN-2 demonstrates effective translational functionality in the fibroblast efficacy model of Wolbachia infection with an EC50 value of 90 nM, utilized at a concentration of 9 μM over 7 days. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.